We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MRBK:NASDAQMeridian Corporation Analysis

Data as of 2026-08-30 - not real-time

$19.32

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Meridian Corporation is neutral at $19.32, with no clear ordering between short and long averages. The last 30 days have lost 4.5%. Momentum indicators put RSI at 40.0 (neutral) with MACD reading bearish. The recent range runs from support at $19.10 up to resistance at $20.76.
The shares look undervalued, trading on 10.6 times earnings below a sector average of 17.0. The average analyst target implies 21.6% above today's level. Revenue is growing at 3.7% on a 19.1% profit margin. The 2.89% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 16.8%, a beta of 0.42 and a maximum drawdown of 17.2%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on buy — conviction 7 out of 10.

Top Market Events

Meridian Corp missed on both earnings and revenue as a $23.MALVERN, Pa., July 30, 2026 GLOBE NEWSWIRE -- Meridian Corporation Nasdaq: MRBK today reported:MALVERN, Pa., July 30, 2026 GLOBE NEWSWIRE -- Meridian Corporation Nasdaq: MRBK today reported: Three Months Ended...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 18.70
  • MACD momentum is negative
  • RSI at 40.0 is in neutral territory

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 10.6 versus sector average of 17.0
  • Trading above the 200-day average of 18.70
  • Analyst targets imply +21.6% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 10.6 versus sector average of 17.0
  • Analyst targets imply +21.6% versus the current price
  • Profit margin of 19.1% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth3.70%
Profit Margin19.06%
P/E Ratio10.6
ROE11.31%
ROA0.85%
P/B Ratio1.1
Op. Cash Flow$20.2M
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI40.0
Support$19.10
Resistance$20.76
MA 20$19.73
MA 50$19.84
MA 200$18.70
MACDBearish
VolumeIncreasing
Fear & Greed Index95.66

Valuation

Fair Value$7.62
Target Price$23.50
Upside/Downside21.64%
GradeUndervalued
TypeValue
Dividend Yield2.89%

Risk Assessment

Beta0.42
Volatility16.80%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.